Bleakley Financial Group LLC Sells 12,965 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Bleakley Financial Group LLC cut its holdings in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 42.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 17,938 shares of the company's stock after selling 12,965 shares during the period. Bleakley Financial Group LLC's holdings in Privia Health Group were worth $351,000 as of its most recent SEC filing.

Several other institutional investors have also added to or reduced their stakes in PRVA. Riverbridge Partners LLC raised its position in Privia Health Group by 19.7% in the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company's stock worth $113,868,000 after acquiring an additional 958,418 shares during the period. Eventide Asset Management LLC raised its position in Privia Health Group by 979.2% in the third quarter. Eventide Asset Management LLC now owns 822,438 shares of the company's stock worth $14,977,000 after acquiring an additional 746,231 shares during the period. Icon Wealth Advisors LLC raised its position in Privia Health Group by 1,910.1% in the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company's stock worth $5,479,000 after acquiring an additional 285,920 shares during the period. FMR LLC raised its position in Privia Health Group by 1.5% in the third quarter. FMR LLC now owns 18,169,043 shares of the company's stock worth $330,858,000 after acquiring an additional 271,645 shares during the period. Finally, Barclays PLC raised its position in Privia Health Group by 240.3% in the third quarter. Barclays PLC now owns 224,018 shares of the company's stock worth $4,079,000 after acquiring an additional 158,188 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Privia Health Group Stock Performance

PRVA stock traded up $0.37 during trading on Friday, hitting $25.24. 764,095 shares of the company's stock traded hands, compared to its average volume of 537,066. Privia Health Group, Inc. has a 52 week low of $15.92 and a 52 week high of $25.49. The business has a fifty day simple moving average of $21.62 and a 200 day simple moving average of $20.23. The stock has a market capitalization of $3.03 billion, a price-to-earnings ratio of 252.43, a P/E/G ratio of 3.07 and a beta of 0.87.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on PRVA shares. Macquarie began coverage on shares of Privia Health Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $25.00 price target on the stock. JPMorgan Chase & Co. increased their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research note on Friday, November 29th. Needham & Company LLC began coverage on shares of Privia Health Group in a research note on Friday, January 10th. They issued a "buy" rating and a $25.00 price objective for the company. Truist Financial increased their price objective on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. Finally, Stephens reissued an "overweight" rating and issued a $26.00 price objective on shares of Privia Health Group in a research note on Thursday, January 2nd. Two analysts have rated the stock with a hold rating, fifteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Privia Health Group presently has an average rating of "Buy" and a consensus target price of $24.94.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.